GB Pharma Holdings

GB Pharma Holdings Inc. is an Washington D.C. global Pharmaceutical company with expertise in defining policies, facilitating approvals, distribution and cGMP (Good Manufacturing Practices). GB Pharma Holdings is a comprehensive pharmaceutical management and consulting service agency, wholesale pharmaceutical distributer, cGMP manufacturer and conduit for accessing quality international pharmaceutical and medical products. Due to a lack of tested and sustainable pharmaceutical products available to sub-Saharan Africa GB Pharma Holdings was established in order to be on the forefront of change and “providing innovative and sustainable solutions while doing good and doing well.

GB Pharma Holdings is dedicated to bringing cost effective and quality products to Africa. We are able to link new technologies, science and education together to be a cause for good. GB Pharma Holdings core focus is twofold; manufacturing cGMP quality pharmaceuticals and helping existing government agencies develop testing and regulations to purge counterfeit and sub-potent products out of their respective countries. Our state-of-the-art cGMP facility currently being developed will serve as the new standard for creating products for Africa. This facility will develop reformulated active ingredients which will lower the overall costs of antiviral, anti-infective and other medications endemic to Africa.